- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (28)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (228)
- Breast Cancer (712)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (110)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (6)
- Kidney Cancer (124)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (98)
- Ovarian Cancer (172)
- Pancreatic Cancer (166)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (234)
- Skin Cancer (294)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (622)
- Complementary Integrative Medicine (22)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (224)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (122)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (116)
- Molecular Diagnostics (8)
- Pain Management (64)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (882)
- Research (384)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (598)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (404)
- Survivorship (324)
- Symptoms (182)
- Treatment (1764)
Less invasive surgery gets a triathlete back on track
2 minute read | Published June 27, 2016
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on June 27, 2016
When triathlete Maria Lea De Jesus was diagnosed with early stage cervical cancer in 2014 after a routine Pap test, she feared being sidelined from her sport.
“I run -- a lot. I just can’t sit still,” says Lea, 49. She trains for endurance sports six days a week, year-round. Her accomplishments include completing over 10 marathons and two IRONMAN triathlons – a 2.4-mile swim, followed by a 112-mile bike ride and a 26.2-mile run.
Lea works as an ultrasound technologist at MD Anderson. So, after her initial diagnosis, she asked a co-worker to recommend an oncologist. She was quickly referred to Kathleen Schmeler, M.D.
“I trusted Dr. Schmeler the minute I met her,” Lea says. “She just has a positive aura.”
Simple hysterectomy for a quick recovery
Lea had two biopsies and an MRI to stage her disease and determine the best course of treatment.
Her care team decided that Lea would have a simple hysterectomy as part of Schmeler’s ConCerv trial, an innovative study using less radical surgery for cervical cancer. This approach removes the uterus and cervix as well as surrounding lymph nodes. It’s an alternative to the standard radical hysterectomy, which also removes surrounding parametrial tissue and the top part of the vagina.
“I read a lot about it and knew Dr. Schmeler was only going to take out what was necessary,” says Lea, adding that she wasn’t nervous for the surgery.
She recalls the operating room as all smiling faces. “I remember Dr. Schmeler talking to me and then it felt like I was dreaming,” Lea says. “I woke-up in the post-anesthesia care unit feeling relatively strong.”
The next day, Lea went home.
Back to triathlon training
“The less invasive procedure has fewer side effects and helped Lea get back to work and training sooner,” Schmeler says. Lea completed a half-marathon mountain run in Canada and the IRONMAN 70.3 Austin less than six months post-surgery.
But Lea also values her post-surgery recovery time, which she calls a month-long rest day. “It was the first time I took a break from training since ... I don’t even know,” she says.
During her recovery, Lea woke-up early every morning and walked her dogs. “I was able to think more and feel more,” she says. “It was a totally different experience for me.”
Don’t skip your Pap test
Lea is thankful to have been part of the research for a less invasive procedure for cervical cancer. She encourages other women with early stage disease to take her same path.
But here’s her most important advice to other women: don’t skip your Pap test. Catching cancer early, Lea says, allowed her to have a simple procedure, recover more quickly and go on with her life cancer-free.

I trusted Dr. Schmeler the minute I met her.
Lea De Jesus
Survivor